Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer

被引：0
作者：
Irena Saarinen
Ivan Jambor
Mai Kim
Anna Kuisma
Jukka Kemppainen
Harri Merisaari
Olli Eskola
Anna-Riina Koskenniemi
Ileana Montoya Perez
Peter Boström
Pekka Taimen
Heikki Minn
机构：
[1] Institute of Biomedicine,Department of Radiology
[2] University of Turku and Department of Pathology,Department of Oral and Maxillofacial Surgery. Plastic Surgery
[3] Turku University Hospital,Department of Diagnostic Radiology and Nuclear Medicine
[4] University of Turku ,Department of Oncology and Radiotherapy
[5] Department of Radiology,Department of Clinical Physiology and Nuclear Medicine
[6] Icahn School of Medicine at Mount Sinai,Department of Future Technologies
[7] New York,Department of Urology
[8] Gunma University Graduate School of Medicine,undefined
[9] Gunma University Graduate School of Medicine,undefined
[10] Turku PET Centre,undefined
[11] Turku University Hospital,undefined
[12] Turku University Hospital,undefined
[13] University of Turku,undefined
[14] Turku University Hospital,undefined
来源：
EJNMMI Research | / 9卷
关键词：
F-fluciclovine; Amino acid transporter; ASCT2; LAT1; Prostate cancer; PET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 117 条
[1]  
Hamdy FC(2016)10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer N Engl J Med 375 1415-1424
[2]  
Donovan JL(2017)Imaging of prostate cancer using fluciclovine PET Clin 12 145-157
[3]  
Lane JA(2016)Molecular imaging of prostate cancer Radiographics 36 142-159
[4]  
Mason M(2011)Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer J Nucl Med 52 822-829
[5]  
Metcalfe C(2005)Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15 254-266
[6]  
Holding P(2014)ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer Br J Cancer 110 2030-2039
[7]  
Savir-Baruch B(2014)Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer Br J Cancer 110 2506-2513
[8]  
Zanoni L(2015)[(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells Nucl Med Biol 42 887-892
[9]  
Schuster DM(2018)Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial) Eur J Nucl Med Mol Imaging 45 355-364
[10]  
Wibmer AG(2015)Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy J Magn Reson Imaging 41 1394-1404
12345678910